Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 986

1.

[Reconstitution of the hematopoietic system and clinical applications of iPS cells].

Sugimoto N, Eto K.

Rinsho Ketsueki. 2019;60(9):1046-1055. doi: 10.11406/rinketsu.60.1046. Japanese.

PMID:
31597826
2.

GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.

Fujiyama H, Tsuji T, Hironaka K, Yoshida K, Sugimoto N, Fujita M.

J Biochem. 2019 Sep 23. pii: mvz075. doi: 10.1093/jb/mvz075. [Epub ahead of print]

PMID:
31545368
3.

Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.

Sasaki M, Nakamura M, Mukumoto N, Goto Y, Ishihara Y, Nakata M, Sugimoto N, Mizowaki T.

J Appl Clin Med Phys. 2019 Sep 20. doi: 10.1002/acm2.12720. [Epub ahead of print]

PMID:
31539194
4.

In situ condensation of an anti-cancer drug into fibrin gel enabling effective inhibition of tumor cell growth.

Kuwahara M, Fujita H, Kataoka Y, Nakajima Y, Yamada M, Sugimoto N.

Chem Commun (Camb). 2019 Oct 7;55(78):11679-11682. doi: 10.1039/c9cc06418d. Epub 2019 Sep 16.

PMID:
31524892
5.

Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.

Hamaguchi T, Denda T, Kudo T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T, Itabashi M, Oki E, Sasaki T, Chiron M, Yoshino T.

Cancer Sci. 2019 Sep 14. doi: 10.1111/cas.14198. [Epub ahead of print]

6.

Measurement of water mist particle size generated by rocket launch using a two-wavelength multi-static lidar.

Jin Y, Sugimoto N, Nishizawa T, Yoshitomi T, Sawada A, Sarae W, Hattori A, Yamasaki Y, Okamoto H, Sato K.

Appl Opt. 2019 Aug 10;58(23):6274-6279. doi: 10.1364/AO.58.006274.

PMID:
31503770
7.

Stabilization of DNA Loop Structures by Large Cations.

Nakano SI, Ayusawa T, Tanino Y, Sugimoto N.

J Phys Chem B. 2019 Sep 12;123(36):7687-7694. doi: 10.1021/acs.jpcb.9b06074. Epub 2019 Aug 29.

PMID:
31465227
8.

A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week).

Nanke Y, Kobashigawa T, Sugimoto N, Yamanaka H, Kotake S.

Immunol Med. 2019 Jun;42(2):99-102. doi: 10.1080/25785826.2019.1657255. Epub 2019 Aug 25.

PMID:
31446856
9.

Quantitative Analysis of Stall of Replicating DNA Polymerase by G-Quadruplex Formation.

Takahashi S, Sugimoto N.

Methods Mol Biol. 2019;2035:257-274. doi: 10.1007/978-1-4939-9666-7_15.

PMID:
31444755
10.

Corticosterone inhibits the expression of cannabinoid receptor-1 and cannabinoid receptor agonist-induced decrease in cell viability in glioblastoma cells.

Sugimoto N, Ishibashi H, Ueda Y, Nakamura H, Yachie A, Ohno-Shosaku T.

Oncol Lett. 2019 Aug;18(2):1557-1563. doi: 10.3892/ol.2019.10456. Epub 2019 Jun 7.

11.

Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden.

Kitai T, Yamanaka K, Sugimoto N, Inamoto O.

Surg Today. 2019 Jul 30. doi: 10.1007/s00595-019-01856-z. [Epub ahead of print]

PMID:
31363844
12.

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.

Cancer Sci. 2019 Sep;110(9):2875-2883. doi: 10.1111/cas.14117. Epub 2019 Jul 23.

13.

Optimization and characterization of red pigment production from an endophytic fungus, Nigrospora aurantiaca CMU-ZY2045, and its potential source of natural dye for use in textile dyeing.

Suwannarach N, Kumla J, Nishizaki Y, Sugimoto N, Meerak J, Matsui K, Lumyong S.

Appl Microbiol Biotechnol. 2019 Sep;103(17):6973-6987. doi: 10.1007/s00253-019-09926-5. Epub 2019 Jun 26.

PMID:
31243502
14.

Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide.

Yamamoto K, Kitawaki T, Sugimoto N, Fujita H, Kawase Y, Takaori-Kondo A, Kadowaki N.

Immunol Lett. 2019 Jul;211:41-48. doi: 10.1016/j.imlet.2019.05.012. Epub 2019 May 26.

PMID:
31141702
15.

Conformational Dynamics of the RNA G-Quadruplex and its Effect on Translation Efficiency.

Endoh T, Sugimoto N.

Molecules. 2019 Apr 24;24(8). pii: E1613. doi: 10.3390/molecules24081613.

16.

Determination of perillaldehyde in perilla herbs using relative molar sensitivity to single-reference diphenyl sulfone.

Masumoto N, Nishizaki Y, Maruyama T, Igarashi Y, Nakajima K, Yamazaki T, Kuroe M, Numata M, Ihara T, Sugimoto N, Sato K.

J Nat Med. 2019 Jun;73(3):566-576. doi: 10.1007/s11418-019-01306-7. Epub 2019 Apr 23.

PMID:
31016636
17.

Theobromine Improves Working Memory by Activating the CaMKII/CREB/BDNF Pathway in Rats.

Islam R, Matsuzaki K, Sumiyoshi E, Hossain ME, Hashimoto M, Katakura M, Sugimoto N, Shido O.

Nutrients. 2019 Apr 20;11(4). pii: E888. doi: 10.3390/nu11040888.

18.

αIIbβ3 changes gears in MKs and platelets.

Sugimoto N, Eto K.

Blood. 2019 Apr 18;133(16):1700-1701. doi: 10.1182/blood-2019-01-896092. No abstract available.

PMID:
31000515
19.

Identification, characterization, and structural analyses of a fungal endo-β-1,2-glucanase reveal a new glycoside hydrolase family.

Tanaka N, Nakajima M, Narukawa-Nara M, Matsunaga H, Kamisuki S, Aramasa H, Takahashi Y, Sugimoto N, Abe K, Terada T, Miyanaga A, Yamashita T, Sugawara F, Kamakura T, Komba S, Nakai H, Taguchi H.

J Biol Chem. 2019 May 10;294(19):7942-7965. doi: 10.1074/jbc.RA118.007087. Epub 2019 Mar 29.

PMID:
30926603
20.

A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.

Nishikawa K, Murotani K, Fujitani K, Inagaki H, Akamaru Y, Tokunaga S, Takagi M, Tamura S, Sugimoto N, Shigematsu T, Yoshikawa T, Ishiguro T, Nakamura M, Hasegawa H, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J, Tsujinaka T.

Cancer Chemother Pharmacol. 2019 May;83(5):867-874. doi: 10.1007/s00280-019-03802-9. Epub 2019 Feb 26.

PMID:
30806758
21.

RNA-Capturing Microsphere Particles (R-CAMPs) for Optimization of Functional Aptamers.

Endoh T, Ohyama T, Sugimoto N.

Small. 2019 Jun;15(26):e1805062. doi: 10.1002/smll.201805062. Epub 2019 Feb 18.

PMID:
30773785
22.

Validation of the nearest-neighbor model for Watson-Crick self-complementary DNA duplexes in molecular crowding condition.

Ghosh S, Takahashi S, Endoh T, Tateishi-Karimata H, Hazra S, Sugimoto N.

Nucleic Acids Res. 2019 Apr 23;47(7):3284-3294. doi: 10.1093/nar/gkz071.

23.

Allergy to carminic acid: in vitro evidence of involvement of protein-binding hapten.

Osumi M, Yamaguchi M, Sugimoto N, Suzukawa M, Arai H, Akiyama H, Nagase H, Ohta K.

Asia Pac Allergy. 2019 Jan 14;9(1):e2. doi: 10.5415/apallergy.2019.9.e2. eCollection 2019 Jan.

24.

Bisubstrate Function of RNA Polymerases Triggered by Molecular Crowding Conditions.

Takahashi S, Okura H, Sugimoto N.

Biochemistry. 2019 Feb 26;58(8):1081-1093. doi: 10.1021/acs.biochem.8b01204. Epub 2019 Feb 15.

PMID:
30714721
25.

Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.

Ujino M, Miyoshi S, Sugimoto N, Arai H, Ota Y, Sasajima Y, Kawamura M, Nagase H, Yamaguchi M, Ohta K.

Intern Med. 2019 Jun 15;58(12):1759-1764. doi: 10.2169/internalmedicine.2080-18. Epub 2019 Feb 1.

26.

Neurometabolic and functional connectivity basis of prosocial behavior in early adolescence.

Okada N, Yahata N, Koshiyama D, Morita K, Sawada K, Kanata S, Fujikawa S, Sugimoto N, Toriyama R, Masaoka M, Koike S, Araki T, Kano Y, Endo K, Yamasaki S, Ando S, Nishida A, Hiraiwa-Hasegawa M, Edden RAE, Barker PB, Sawa A, Kasai K.

Sci Rep. 2019 Jan 24;9(1):732. doi: 10.1038/s41598-018-38355-z.

27.

Heat attenuates sensitivity of mammalian cells to capsaicin.

Sugimoto N, Matsuzaki K, Katakura M, Nakamura H, Ueda Y, Yachie A, Shido O.

J Biochem Mol Toxicol. 2019 May;33(5):e22288. doi: 10.1002/jbt.22288. Epub 2019 Jan 23.

PMID:
30672650
28.

Relative molar sensitivities of carnosol and carnosic acid with respect to diphenylamine allow accurate quantification of antioxidants in rosemary extract.

Nishizaki Y, Masumoto N, Nakajima K, Ishizuki K, Yamazaki T, Kuroe M, Numata M, Ihara T, Tada A, Sugimoto N, Sato K.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2019 Feb;36(2):203-211. doi: 10.1080/19440049.2018.1556817. Epub 2019 Jan 22.

PMID:
30668225
29.

Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.

Denda T, Sakai D, Hamaguchi T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T, Itabashi M, Oki E, Sasaki T, Sunaga Y, Ziti-Ljajic S, Brillac C, Yoshino T.

Cancer Sci. 2019 Mar;110(3):1032-1043. doi: 10.1111/cas.13943. Epub 2019 Feb 22.

30.

Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.

Morii I, Iwabuchi Y, Mori S, Suekuni M, Natsume T, Yoshida K, Sugimoto N, Kanemaki MT, Fujita M.

Cancer Sci. 2019 Mar;110(3):1044-1053. doi: 10.1111/cas.13941. Epub 2019 Feb 14.

31.

Planetary-scale streak structure reproduced in high-resolution simulations of the Venus atmosphere with a low-stability layer.

Kashimura H, Sugimoto N, Takagi M, Matsuda Y, Ohfuchi W, Enomoto T, Nakajima K, Ishiwatari M, Sato TM, Hashimoto GL, Satoh T, Takahashi YO, Hayashi YY.

Nat Commun. 2019 Jan 9;10(1):23. doi: 10.1038/s41467-018-07919-y.

32.

Characterization of Intracellular Crowding Environments with Topology-Based DNA Quadruplex Sensors.

Takahashi S, Yamamoto J, Kitamura A, Kinjo M, Sugimoto N.

Anal Chem. 2019 Feb 19;91(4):2586-2590. doi: 10.1021/acs.analchem.8b04177. Epub 2019 Jan 10.

33.

Population-neuroscience study of the Tokyo TEEN Cohort (pn-TTC): Cohort longitudinal study to explore the neurobiological substrates of adolescent psychological and behavioral development.

Okada N, Ando S, Sanada M, Hirata-Mogi S, Iijima Y, Sugiyama H, Shirakawa T, Yamagishi M, Kanehara A, Morita M, Yagi T, Hayashi N, Koshiyama D, Morita K, Sawada K, Ikegame T, Sugimoto N, Toriyama R, Masaoka M, Fujikawa S, Kanata S, Tada M, Kirihara K, Yahata N, Araki T, Jinde S, Kano Y, Koike S, Endo K, Yamasaki S, Nishida A, Hiraiwa-Hasegawa M, Bundo M, Iwamoto K, Tanaka SC, Kasai K.

Psychiatry Clin Neurosci. 2019 May;73(5):231-242. doi: 10.1111/pcn.12814. Epub 2019 Feb 19.

PMID:
30588712
34.

Anti-interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis.

Tomyo F, Sugimoto N, Kawamoto M, Nagase H, Yamaguchi M, Ohta K.

Respirol Case Rep. 2018 Dec 18;7(2):e00397. doi: 10.1002/rcr2.397. eCollection 2019 Feb.

35.

Design and Properties of Ligand-Conjugated Guanine Oligonucleotides for Recovery of Mutated G-Quadruplexes.

Takahashi S, Chelobanov B, Kim KT, Kim BH, Stetsenko D, Sugimoto N.

Molecules. 2018 Dec 6;23(12). pii: E3228. doi: 10.3390/molecules23123228.

36.

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).

Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Nakajima TE, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N.

Gastric Cancer. 2019 Mar;22(2):344-354. doi: 10.1007/s10120-018-0899-6. Epub 2018 Dec 1.

37.

Abnormal asymmetries in subcortical brain volume in early adolescents with subclinical psychotic experiences.

Okada N, Yahata N, Koshiyama D, Morita K, Sawada K, Kanata S, Fujikawa S, Sugimoto N, Toriyama R, Masaoka M, Koike S, Araki T, Kano Y, Endo K, Yamasaki S, Ando S, Nishida A, Hiraiwa-Hasegawa M, Kasai K.

Transl Psychiatry. 2018 Nov 28;8(1):254. doi: 10.1038/s41398-018-0312-6.

38.

Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Yamada S, Shimizu M, Kuroda M, Inoue N, Sugimoto N, Yachie A.

Clin Exp Nephrol. 2019 Apr;23(4):544-550. doi: 10.1007/s10157-018-1675-y. Epub 2018 Nov 22.

PMID:
30467800
39.

Chronic administration of theobromine inhibits mTOR signal in rats.

Sugimoto N, Katakura M, Matsuzaki K, Sumiyoshi E, Yachie A, Shido O.

Basic Clin Pharmacol Toxicol. 2019 May;124(5):575-581. doi: 10.1111/bcpt.13175. Epub 2018 Dec 12.

PMID:
30451374
40.

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

Fujita Y, Taguri M, Yamazaki K, Tsurutani J, Sakai K, Tsushima T, Nagase M, Tamagawa H, Ueda S, Tamura T, Tsuji Y, Murata K, Taira K, Denda T, Moriwaki T, Funai S, Nakajima TE, Muro K, Tsuji A, Yoshida M, Suyama K, Kurimoto T, Sugimoto N, Baba E, Seki N, Sato M, Shimura T, Boku N, Hyodo I, Yamanaka T, Nishio K.

Oncologist. 2019 Mar;24(3):327-337. doi: 10.1634/theoncologist.2018-0119. Epub 2018 Nov 13.

PMID:
30425180
41.

A Turn-On Detection of DNA Sequences by Means of Fluorescence of DNA-Templated Silver Nanoclusters via Unique Interactions of a Hydrated Ionic Liquid.

Teng Y, Tateishi-Karimata H, Tsuruoka T, Sugimoto N.

Molecules. 2018 Nov 6;23(11). pii: E2889. doi: 10.3390/molecules23112889.

42.

Membrane Dynamics Induced by a Phosphatidylinositol 3,4,5-Trisphosphate Optogenetic Tool.

Ueda Y, Ii T, Aono Y, Sugimoto N, Shinji S, Yoshida H, Sato M.

Anal Sci. 2019 Jan 10;35(1):57-63. doi: 10.2116/analsci.18SDP06. Epub 2018 Nov 2.

43.

Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.

Yagi T, Fujiishi K, Hasegawa A, Otsuka T, Yoshinami T, Nishio M, Fujisawa F, Sugimoto N, Imamura F.

Breast Cancer. 2019 Mar;26(2):229-234. doi: 10.1007/s12282-018-0918-9. Epub 2018 Oct 22.

PMID:
30350259
44.

Mirror-Image Dependence: Targeting Enantiomeric G-Quadruplex DNA Using Triplex Metallohelices.

Zhao C, Song H, Scott P, Zhao A, Tateishi-Karimata H, Sugimoto N, Ren J, Qu X.

Angew Chem Int Ed Engl. 2018 Nov 26;57(48):15723-15727. doi: 10.1002/anie.201809207. Epub 2018 Nov 2.

PMID:
30311333
45.

[Ex vivo platelet production from induced pluripotent stem cells].

Sugimoto N, Eto K.

Rinsho Ketsueki. 2018;59(10):1905-1913. doi: 10.11406/rinketsu.59.1905. Review. Japanese.

PMID:
30305491
46.

A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L).

Akamatsu H, Harada H, Tokunaga S, Yoshimura N, Ikeda H, Oizumi S, Sugimoto N, Takano T, Murakami H, Nishimura Y, Yamamoto N, Nakagawa K.

Clin Lung Cancer. 2019 Jan;20(1):e25-e27. doi: 10.1016/j.cllc.2018.08.017. Epub 2018 Aug 30.

47.

JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps.

Nakayama T, Sugimoto N, Okada N, Tsurumoto T, Mitsuyoshi R, Takaishi S, Asaka D, Kojima H, Yoshikawa M, Tanaka Y, Haruna SI.

Auris Nasus Larynx. 2019 Jun;46(3):374-383. doi: 10.1016/j.anl.2018.09.004. Epub 2018 Sep 19.

PMID:
30243753
48.

IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice.

Sugimoto N, Suzukawa M, Nagase H, Koizumi Y, Ro S, Kobayashi K, Yoshihara H, Kojima Y, Kamiyama-Hara A, Hebisawa A, Ohta K.

Am J Respir Cell Mol Biol. 2019 Feb;60(2):232-243. doi: 10.1165/rcmb.2017-0287OC.

PMID:
30240278
49.

A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production.

Seo H, Chen SJ, Hashimoto K, Endo H, Nishi Y, Ohta A, Yamamoto T, Hotta A, Sawaguchi A, Hayashi H, Koseki N, Murphy GJ, Fukuda K, Sugimoto N, Eto K.

Blood Adv. 2018 Sep 11;2(17):2262-2272. doi: 10.1182/bloodadvances.2018019547.

50.

Co-Transcriptional Molecular Assembly Results in a Kinetically Controlled Irreversible RNA Conformational Switch.

Endoh T, Sugimoto N.

Anal Chem. 2018 Oct 2;90(19):11193-11197. doi: 10.1021/acs.analchem.8b03427. Epub 2018 Sep 12.

PMID:
30198708

Supplemental Content

Loading ...
Support Center